These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15317829)

  • 41. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Population pharmacokinetics of amlodipine in hypertensive children and adolescents.
    Flynn JT; Nahata MC; Mahan JD; Portman RJ;
    J Clin Pharmacol; 2006 Aug; 46(8):905-16. PubMed ID: 16855075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers.
    Hassan Y; Alfadly SO; Azmin MN; Peh KK; Tan TF; Noorizan AA; Ismail O
    Singapore Med J; 2007 Sep; 48(9):819-23. PubMed ID: 17728962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of ciprofloxacin concentrations in human serum and urine by HPLC with ultraviolet and fluorescence detection.
    Sowinski KM; Kays MB
    J Clin Pharm Ther; 2004 Aug; 29(4):381-7. PubMed ID: 15271106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans.
    Olsen GW; Chang SC; Noker PE; Gorman GS; Ehresman DJ; Lieder PH; Butenhoff JL
    Toxicology; 2009 Feb; 256(1-2):65-74. PubMed ID: 19059455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
    De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
    Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
    Stroshane RM; Silverman MH; Sauerschell R; Brown RR; Boddy AW; Cook JA
    Antimicrob Agents Chemother; 1990 May; 34(5):751-4. PubMed ID: 2360815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic and pharmacodynamic interactions between intravenous ciprofloxacin and oral ferrous sulfate.
    Wong PY; Zhu M; Li RC
    J Chemother; 2000 Aug; 12(4):286-93. PubMed ID: 10949977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of trough concentrations of oral ciprofloxacin.
    Paladino JA; Forrest A; Wilton JH
    Pharmacotherapy; 1993; 13(5):504-7. PubMed ID: 8247920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of chronic cadmium exposure on the pharmacokinetics of theophylline and ciprofloxacin in rats.
    Zaghloul IY; Radwan MA; Aly ZH
    J Trace Elem Med Biol; 2007; 21(2):132-7. PubMed ID: 17499154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of ciprofloxacin in impaired liver function.
    Esposito S; Miniero M; Barba D; Sagnelli E
    Int J Clin Pharmacol Res; 1989; 9(1):37-41. PubMed ID: 2707924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
    Kim MK; Nightingale C; Nicolau D
    Clin Pharmacokinet; 2003; 42(11):985-96. PubMed ID: 12908854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis).
    Saini SP; Srivastava AK
    Vet Res Commun; 2001 Dec; 25(8):641-9. PubMed ID: 11767010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age and sex effects on the pharmacokinetics of linezolid.
    Sisson TL; Jungbluth GL; Hopkins NK
    Eur J Clin Pharmacol; 2002 Jan; 57(11):793-7. PubMed ID: 11868801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.